Websites targeting keyword non small cell lung cancer

CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).

Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer (NSCLC). Find information about taking ALIMTA for the treatment of advanced NS NSCLC.

OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.

Learn about Rx XALKORI® (crizotinib) for treatment of ALK+ or ROS1+ non-small cell lung cancer that has spread to other parts of the body. See risks & benefits.

CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).

Learn about Alunbrig (brigatinib), a treatment that could be right for you

Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.

This website is intended to facilitate the use of the AZ UK EGFR Plasma testing service for Oncologists managing patients with advanced non-small cell lung cancer.

Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.